714 ATOR-1017, a 4–1BB antibody, demonstrates promising safety and proof of mechanism in a first-in-human study in patients with advanced solid malignancies | Zendy

AI Assistant Blog Pricing

714 ATOR-1017, a 4–1BB antibody, demonstrates promising safety and proof of mechanism in a first-in-human study in patients with advanced solid malignancies

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.